Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
For the better part of a century, laboratories had been among the most local of health care providers. But in recent decades, that dynamic has taken a 180-degree turn…
From - Laboratory Industry Report
Transgenomic has released two new liquid biopsy tests for colorectal cancer and metastatic melanoma…
From - Laboratory Industry Report
Veritas Genetics is launching a whole genome test under the four-figure price point…
From - Laboratory Industry Report
LifeCode Health has been acquired by an Indian company that will use its assets as a foothold into the U.S. market…